The Centers for Disease Control and Prevention (CDC) intends to purchase the following: The CDC intends to award a contract with a vendor that has gnotobiotic piglet facility and an excellent track record in the area of rotavirus vaccine research. The investigators should have sensitivity to the issues of rotavirus epidemiology, immunology, and a laboratory infrastructure that will enable them to collect these specimens on a timely basis and with complete follow up. The vendor shall have all reagents and assays in place to reliably complete all laboratory animal tests and provide guidance for future clinical trials in humans. It would be counterproductive for the CDC to have to set up a facility for a vendorwho does not have the prerequisite knowledge and experience with a study that involves complex operation procedures, collection of blood and fecal specimens, performance of various complex immunologic assays, and maintenance and monitoring of vaccinated/infected animals. THIS IS A COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS PREPARED IN ACCORDANCE WITH THE FORMAT IN SUBPART 12.6, AS SUPPLEMENTED WITH ADDITIONAL INFORMATION INCLUDED IN THIS NOTICE.     THIS ANNOUNCEMENT CONSTITUTES THE ONLY WILL NOT BE ISSUED. The following provision(s) apply to this acquisition: 52.212-1 Instructions to Offerors ? Commercial Items (MAR 2000) applies to this acquisition; 52.223-13 Certification of Toxic Chemical Release Reporting; 52.223-14 Toxic Chemical Release Reporting; 52.232-1 Payments; 52.233-3 Protest After Award; 52.201-1 Definitions; 52.203-5 Covenant Against Contingent Fees; 52.203-7 Anti-Kickback Procedures; 52.204-7 Central Contractor Registration; Contractor must be CCR Registered prior to submitting bid; The clause 52.212-4, Contract Terms & Conditions - Commercial Items (MAY 1999) applies to this acquisition. The following FAR Clauses are hereby added to this clause: 52.247-35 F.O.B. Destination; The clause at 52.212-5 - Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following clauses listed in paragraph (b) of 52.212-5 apply to this acquisition: (1), (5), (7), (14), (15), (16), (17), (18), (22), (24), (29) and (30). 52.213-3 must be attached to bid. NAICS CODE: 424210, SIC: 5122 SIZE: 100, OFFERORS SHALL INCLUDE A COMPLETED COPY OF THE PROVISION AT 52.212-3, OFFERORS REPRESENTATIONS AND CERTIFICATIONS - COMMERCIAL ITEMS, WITH YOUR QUOTE.     The best way to complete this certification is to download the FAR Clauses (Volume II) at http://www.arnet.gov/far, print out the clause 52.212-3, Offeror Representation and Certification, and fill in the appropriate blanks.     Documentation authority for synopsis urgent response on file. Offers will be due 09/30/2005 by 5:00 P.M. EST at Centers for Disease Control and Prevention; Procurements and Grants Office; Attn: Gary Morgan; 2920 Brandywine Road, M/S E18, Room 2903, Atlanta, GA     30341.     Offers will not be accepted by email or facsimile offers. All quotes must be clearly marked on the envelope with the following:     Solicitation# 2005-Q-------, Attn: Gary Morgan.     All responsible sources that can meet the above requirements may submit a quote, which may be considered by the Agency.     For Contractual question contact Gary Morgan (770) 488-2639. ****

Bid Protests Not Available